掌握质量:将风险评估与设计质量 (QbD) 结合为制药卓越的原则
Abdul M Kaleem1, Jebastin Koilpillai1, Damodharan Narayanasamy2
1Pharmacy, SRM Institute of Science and Technology, Chennai, IND.
Cureus
|September 30, 2024
概括
本文探讨了将风险评估与设计质量 (QbD) 整合起来,以提高药品质量. 它提供了在整个药物生命周期中管理风险的工具和方法,确保安全性和有效性.
科学领域:
- 制药品质量管理 制药品质量管理
- 药物开发和制造 药物开发和制造
背景情况:
- 制药行业面临着持续的发展,需要强有力的药物有效性,安全性和质量战略.
- 确保药品质量的一致性需要采取积极的方法来管理整个产品生命周期的挑战.
研究的目的:
- 展示药品质量挑战的风险评估工具和方法.
- 检查风险评估与设计质量 (QbD) 原则的整合,以提高药品质量.
- 评估关于制药行业风险评估应用的最新文献.
主要方法:
- 对近期关于药品风险评估的文章进行系统审查.
- 分析风险评估方法,强调其优缺点.
- 探索设计质量 (QbD) 原则及其与风险管理的协同作用.
主要成果:
- 风险评估是一种方法方法,用于识别,评估和减轻制药开发和制造中的风险.
- 设计质量 (QbD) 强调从一开始就将质量纳入产品,补充最终产品的测试.
- 风险评估与QbD的整合为制药卓越提供了一个全面的战略.
结论:
- 结合风险评估和QbD对于保持高药品质量标准至关重要.
- 提出的方法提供了在整个产品生命周期中管理药品质量的实际工具.
- 持续适应风险评估和QbD等新策略对于不断变化的制药领域至关重要.
相关概念视频
Quality Assurance
117
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
117
Structure-Activity Relationships and Drug Design
676
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
676
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Pharmacovigilance
784
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
784
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
123
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
123
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K


